Journal
NATURE COMMUNICATIONS
Volume 10, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-08145-2
Keywords
-
Categories
Funding
- National Institutes of Health [ES015869]
- Nebraska Department of Health and Human Services [LB506]
- Swedish Cancer Society
- Swedish Research Council
- University of Nebraska Medical Center Graduate Studies Research Fellowship
Ask authors/readers for more resources
Alterations in the exonuclease domain of DNA polymerase epsilon (Pol epsilon) cause ultramutated tumors. Severe mutator effects of the most common variant, Pol epsilon-P286R, modeled in yeast suggested that its pathogenicity involves yet unknown mechanisms beyond simple proofreading deficiency. We show that, despite producing a catastrophic amount of replication errors in vivo, the yeast Pol epsilon-P286R analog retains partial exonuclease activity and is more accurate than exonuclease-dead Pole. The major consequence of the arginine substitution is a dramatically increased DNA polymerase activity. This is manifested as a superior ability to copy synthetic and natural templates, extend mismatched primer termini, and bypass secondary DNA structures. We discuss a model wherein the cancer-associated substitution limits access of the 3'-terminus to the exonuclease site and promotes binding at the polymerase site, thus stimulating polymerization. We propose that the ultramutator effect results from increased polymerase activity amplifying the contribution of Pol epsilon errors to the genomic mutation rate.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available